Back
Corporate News
MPS Pharma confirms regulatory compliance for the period ended September 30, 2026
07-Oct-2026, 07:51
MPS PHARMAA Limited, formerly Advik Laboratories Limited, submitted a certificate to the Bombay Stock Exchange and Ahmedabad Stock Exchange on October 7, 2026, confirming compliance with Regulation 74(5) of the SEBI (Depository and Participant) Regulations, 2018, for the quarter and half year ended September 30, 2026, as per confirmation provided by MAS Services Private Limited, the company's Registrar and Share Transfer Agent.
